Urban Wealth Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Urban Wealth Management’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$29K	Buy	+4,691	New	+$15.8K	0.1%	124

Other funds holding FSTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Urban Wealth Management's FSTX Position: Q2 2022 in Review

Urban Wealth Management opened a new position in F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2022: 4,691 shares worth $29K. The stake represents 0.1% of the portfolio and ranks #124 among its holdings.

53 funds tracked by Wall St. Rank hold FSTX as of Q2 2022.

Urban Wealth Management held 4,691 shares of F-star Therapeutics, Inc. Common Stock worth $29K as of Q2 2022.
F-star Therapeutics, Inc. Common Stock was a new Urban Wealth Management position in Q2 2022.
F-star Therapeutics, Inc. Common Stock made up 0.1% of Urban Wealth Management's portfolio in Q2 2022, its #124 holding.
53 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.